Additional file 1 of Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: a clinicogenomic TCGA study

Table_2_An enhanced genetic mutation-based model for predicting the efficacy of immune checkpoint inhibitors in patients with melanoma.xlsx

Chaohu Pan (11048957)
Hongzhen Tang (12216098)
Wei Wang (17594)
Dongfang Wu (585045)
Haitao Luo (365511)
Libin Xu (1314657)
Xue-Jia Lin (14434449)

January 2023

BackgroundProgrammed death ligand 1 (PD-L1) and tumor mutation burden (TMB) have been developed as b...

Table_1_An enhanced genetic mutation-based model for predicting the efficacy of immune checkpoint inhibitors in patients with melanoma.xlsx

Chaohu Pan (11048957)
Hongzhen Tang (12216098)
Wei Wang (17594)
Dongfang Wu (585045)
Haitao Luo (365511)
Libin Xu (1314657)
Xue-Jia Lin (14434449)

January 2023

BackgroundProgrammed death ligand 1 (PD-L1) and tumor mutation burden (TMB) have been developed as b...

Table_1_Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanoma.DOCX

Devayani Machiraju (14490179)
Sarah Schäfer (4642096)
Philip Beckhove (14490182)
Jasmin Roth (14490185)
Carsten Schulz (4023140)
Jessica C. Hassel (10677911)

January 2023

BackgroundImmune checkpoint inhibitors (ICIs) are the standard of care for metastatic cutaneous mela...

Additional file 3 of Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: a clinicogenomic TCGA study

Mohammed Safi (11216613)
Chenxing Jin (8504973)
Abdullah Aldanakh (11813533)
Ping Feng (501575)
Henan Qin (13583482)
Mohammed Alradhi (12379574)
Lizhi Zhang (1358475)
Junying Zhang (28976)
Salah Adlat (6940217)
Yi Zhao (14034)
Jiwei Liu (829376)

September 2022

Additional file 3: Supplementary Table 3. Characteristics of affiliated hospital for malignant melan...

Additional file 7 of Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: a clinicogenomic TCGA study

Mohammed Safi (11216613)
Chenxing Jin (8504973)
Abdullah Aldanakh (11813533)
Ping Feng (501575)
Henan Qin (13583482)
Mohammed Alradhi (12379574)
Lizhi Zhang (1358475)
Junying Zhang (28976)
Salah Adlat (6940217)
Yi Zhao (14034)
Jiwei Liu (829376)

September 2022

Additional file 7: Supplementary Figure 4. ICI genes were illustrated and described in the context ...

Additional file 8 of Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: a clinicogenomic TCGA study

Mohammed Safi (11216613)
Chenxing Jin (8504973)
Abdullah Aldanakh (11813533)
Ping Feng (501575)
Henan Qin (13583482)
Mohammed Alradhi (12379574)
Lizhi Zhang (1358475)
Junying Zhang (28976)
Salah Adlat (6940217)
Yi Zhao (14034)
Jiwei Liu (829376)

September 2022

Additional file 8: Supplementary Figure 5. Spearman's rho r value and statistical significance of t...

Additional file 6 of Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: a clinicogenomic TCGA study

Mohammed Safi (11216613)
Chenxing Jin (8504973)
Abdullah Aldanakh (11813533)
Ping Feng (501575)
Henan Qin (13583482)
Mohammed Alradhi (12379574)
Lizhi Zhang (1358475)
Junying Zhang (28976)
Salah Adlat (6940217)
Yi Zhao (14034)
Jiwei Liu (829376)

September 2022

Additional file 6: Supplementary Figure 3. The risk score genes as oncosuppressors (their high expr...

Additional file 5 of Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: a clinicogenomic TCGA study

Mohammed Safi (11216613)
Chenxing Jin (8504973)
Abdullah Aldanakh (11813533)
Ping Feng (501575)
Henan Qin (13583482)
Mohammed Alradhi (12379574)
Lizhi Zhang (1358475)
Junying Zhang (28976)
Salah Adlat (6940217)
Yi Zhao (14034)
Jiwei Liu (829376)

September 2022

Additional file 5: Supplementary Figure 2. A. overall survival rate for patients in the high-risk gr...

Additional file 4 of Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: a clinicogenomic TCGA study

Mohammed Safi (11216613)
Chenxing Jin (8504973)
Abdullah Aldanakh (11813533)
Ping Feng (501575)
Henan Qin (13583482)
Mohammed Alradhi (12379574)
Lizhi Zhang (1358475)
Junying Zhang (28976)
Salah Adlat (6940217)
Yi Zhao (14034)
Jiwei Liu (829376)

September 2022

Additional file 4: Supplementary Figure 1: univariate hazard model and multivariate hazard model reg...

Additional file 1: of Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

Carl Morrison (60355)
Sarabjot Pabla (5198024)
Jeffrey Conroy (3479114)
Mary Nesline (5198012)
Sean Glenn (3479126)
Devin Dressman (5198045)
Antonios Papanicolau-Sengos (3479120)
Blake Burgher (3479138)
Jonathan Andreas (663929)
Vincent Giamo (5198036)
Moachun Qin (5198015)
Yirong Wang (363932)
Felicia Lenzo (5198027)
Angela Omilian (3479117)
Wiam Bshara (318111)
Matthew Zibelman (3398630)
Pooja Ghatalia (800258)
Konstantin Dragnev (5198048)
Keisuke Shirai (5198021)
Katherine Madden (5198009)
Laura Tafe (5198018)
Neel Shah (636869)
Deepa Kasuganti (5198042)
Luis de la Cruz-Merino (721536)
Isabel Araujo (5198030)
Yvonne Saenger (5198033)
Margaret Bogardus (5198003)
Miguel Villalona-Calero (3767593)
Zuanel Diaz (5198000)
Roger Day (3400022)
Marcia Eisenberg (5198006)
Steven Anderson (4795494)
Igor Puzanov (5198039)
Lorenzo Galluzzi (82794)
Mark Gardner (2221396)
Marc Ernstoff (3526124)

May 2018

Table S1 Clinical characteristics of the melanoma cohort. Table S2 Survival analyses for studied bio...

MOESM3 of Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts

Sarah Weiss (2657452)
Joseph Han (3455414)
Farbod Darvishian (203431)
Jeremy Tchack (3455417)
Sung Han (3455408)
Karolina Malecek (50297)
Michelle Krogsgaard (242089)
Iman Osman (37169)
Judy Zhong (3455411)

October 2016

Additional file 3: Table S3. A Significant gene expression differences with aging in the IMCG primar...

MOESM2 of Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts

Sarah Weiss (2657452)
Joseph Han (3455414)
Farbod Darvishian (203431)
Jeremy Tchack (3455417)
Sung Han (3455408)
Karolina Malecek (50297)
Michelle Krogsgaard (242089)
Iman Osman (37169)
Judy Zhong (3455411)

October 2016

Additional file 2: Table S2. Clinicopathologic features of 84 IMCG and 43 TCGA primary melanomas in ...

Table1_Significance of immunogenic cell death-related genes in prognosis prediction and immune microenvironment landscape of patients with cutaneous melanoma.XLSX

Weijiang Fu (429365)
Guangxin Ma (12587115)

September 2022

Cutaneous melanoma (CM) is one of the most life-threatening tumors. Although targeted therapies and ...

Additional file 1: of Predominance of triple wild-type and IGF2R mutations in mucosal melanomas

Yuuki Iida (5907662)
Matthew Salomon (3578312)
Keisuke Hata (510174)
Kevin Tran (519050)
Shuichi Ohe (5907671)
Chester Griffiths (5907674)
Sandy Hsu (117448)
Nellie Nelson (5907677)
Dave Hoon (5229374)

October 2018

Clinical characteristics of 89 melanomas. Description of data: Clinical information of each of the 8...

DataSheet_1_Comprehensive characterisation of immunogenic cell death in melanoma revealing the association with prognosis and tumor immune microenvironment.pdf

Jie Ren (176083)
Jiaqi Yang (4380466)
Song Na (13847077)
Yiqian Wang (51946)
Linyun Zhang (1552285)
Jinkui Wang (12011708)
Jiwei Liu (829376)

September 2022

Increasing evidence has highlighted the critical functions of immunogenic cell death (ICD) within ma...

Table_2_An enhanced genetic mutation-based model for predicting the efficacy of immune checkpoint inhibitors in patients with melanoma.xlsx

Chaohu Pan (11048957)
Hongzhen Tang (12216098)
Wei Wang (17594)
Dongfang Wu (585045)
Haitao Luo (365511)
Libin Xu (1314657)
Xue-Jia Lin (14434449)

January 2023

BackgroundProgrammed death ligand 1 (PD-L1) and tumor mutation burden (TMB) have been developed as b...

Table_1_An enhanced genetic mutation-based model for predicting the efficacy of immune checkpoint inhibitors in patients with melanoma.xlsx

Chaohu Pan (11048957)
Hongzhen Tang (12216098)
Wei Wang (17594)
Dongfang Wu (585045)
Haitao Luo (365511)
Libin Xu (1314657)
Xue-Jia Lin (14434449)

January 2023

BackgroundProgrammed death ligand 1 (PD-L1) and tumor mutation burden (TMB) have been developed as b...

Table_1_Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanoma.DOCX

Devayani Machiraju (14490179)
Sarah Schäfer (4642096)
Philip Beckhove (14490182)
Jasmin Roth (14490185)
Carsten Schulz (4023140)
Jessica C. Hassel (10677911)

January 2023

BackgroundImmune checkpoint inhibitors (ICIs) are the standard of care for metastatic cutaneous mela...

Additional file 3 of Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: a clinicogenomic TCGA study

Mohammed Safi (11216613)
Chenxing Jin (8504973)
Abdullah Aldanakh (11813533)
Ping Feng (501575)
Henan Qin (13583482)
Mohammed Alradhi (12379574)
Lizhi Zhang (1358475)
Junying Zhang (28976)
Salah Adlat (6940217)
Yi Zhao (14034)
Jiwei Liu (829376)

September 2022

Additional file 3: Supplementary Table 3. Characteristics of affiliated hospital for malignant melan...

Additional file 7 of Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: a clinicogenomic TCGA study

Mohammed Safi (11216613)
Chenxing Jin (8504973)
Abdullah Aldanakh (11813533)
Ping Feng (501575)
Henan Qin (13583482)
Mohammed Alradhi (12379574)
Lizhi Zhang (1358475)
Junying Zhang (28976)
Salah Adlat (6940217)
Yi Zhao (14034)
Jiwei Liu (829376)

September 2022

Additional file 7: Supplementary Figure 4. ICI genes were illustrated and described in the context ...

Additional file 8 of Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: a clinicogenomic TCGA study

Mohammed Safi (11216613)
Chenxing Jin (8504973)
Abdullah Aldanakh (11813533)
Ping Feng (501575)
Henan Qin (13583482)
Mohammed Alradhi (12379574)
Lizhi Zhang (1358475)
Junying Zhang (28976)
Salah Adlat (6940217)
Yi Zhao (14034)
Jiwei Liu (829376)

September 2022

Additional file 8: Supplementary Figure 5. Spearman's rho r value and statistical significance of t...

Additional file 6 of Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: a clinicogenomic TCGA study

Mohammed Safi (11216613)
Chenxing Jin (8504973)
Abdullah Aldanakh (11813533)
Ping Feng (501575)
Henan Qin (13583482)
Mohammed Alradhi (12379574)
Lizhi Zhang (1358475)
Junying Zhang (28976)
Salah Adlat (6940217)
Yi Zhao (14034)
Jiwei Liu (829376)

September 2022

Additional file 6: Supplementary Figure 3. The risk score genes as oncosuppressors (their high expr...

Additional file 5 of Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: a clinicogenomic TCGA study

Mohammed Safi (11216613)
Chenxing Jin (8504973)
Abdullah Aldanakh (11813533)
Ping Feng (501575)
Henan Qin (13583482)
Mohammed Alradhi (12379574)
Lizhi Zhang (1358475)
Junying Zhang (28976)
Salah Adlat (6940217)
Yi Zhao (14034)
Jiwei Liu (829376)

September 2022

Additional file 5: Supplementary Figure 2. A. overall survival rate for patients in the high-risk gr...

Additional file 4 of Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: a clinicogenomic TCGA study

Mohammed Safi (11216613)
Chenxing Jin (8504973)
Abdullah Aldanakh (11813533)
Ping Feng (501575)
Henan Qin (13583482)
Mohammed Alradhi (12379574)
Lizhi Zhang (1358475)
Junying Zhang (28976)
Salah Adlat (6940217)
Yi Zhao (14034)
Jiwei Liu (829376)

September 2022

Additional file 4: Supplementary Figure 1: univariate hazard model and multivariate hazard model reg...

Additional file 1: of Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

Carl Morrison (60355)
Sarabjot Pabla (5198024)
Jeffrey Conroy (3479114)
Mary Nesline (5198012)
Sean Glenn (3479126)
Devin Dressman (5198045)
Antonios Papanicolau-Sengos (3479120)
Blake Burgher (3479138)
Jonathan Andreas (663929)
Vincent Giamo (5198036)
Moachun Qin (5198015)
Yirong Wang (363932)
Felicia Lenzo (5198027)
Angela Omilian (3479117)
Wiam Bshara (318111)
Matthew Zibelman (3398630)
Pooja Ghatalia (800258)
Konstantin Dragnev (5198048)
Keisuke Shirai (5198021)
Katherine Madden (5198009)
Laura Tafe (5198018)
Neel Shah (636869)
Deepa Kasuganti (5198042)
Luis de la Cruz-Merino (721536)
Isabel Araujo (5198030)
Yvonne Saenger (5198033)
Margaret Bogardus (5198003)
Miguel Villalona-Calero (3767593)
Zuanel Diaz (5198000)
Roger Day (3400022)
Marcia Eisenberg (5198006)
Steven Anderson (4795494)
Igor Puzanov (5198039)
Lorenzo Galluzzi (82794)
Mark Gardner (2221396)
Marc Ernstoff (3526124)

May 2018

Table S1 Clinical characteristics of the melanoma cohort. Table S2 Survival analyses for studied bio...

MOESM3 of Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts

Sarah Weiss (2657452)
Joseph Han (3455414)
Farbod Darvishian (203431)
Jeremy Tchack (3455417)
Sung Han (3455408)
Karolina Malecek (50297)
Michelle Krogsgaard (242089)
Iman Osman (37169)
Judy Zhong (3455411)

October 2016

Additional file 3: Table S3. A Significant gene expression differences with aging in the IMCG primar...

MOESM2 of Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts

Sarah Weiss (2657452)
Joseph Han (3455414)
Farbod Darvishian (203431)
Jeremy Tchack (3455417)
Sung Han (3455408)
Karolina Malecek (50297)
Michelle Krogsgaard (242089)
Iman Osman (37169)
Judy Zhong (3455411)

October 2016

Additional file 2: Table S2. Clinicopathologic features of 84 IMCG and 43 TCGA primary melanomas in ...

Table1_Significance of immunogenic cell death-related genes in prognosis prediction and immune microenvironment landscape of patients with cutaneous melanoma.XLSX

Weijiang Fu (429365)
Guangxin Ma (12587115)

September 2022

Cutaneous melanoma (CM) is one of the most life-threatening tumors. Although targeted therapies and ...

Additional file 1: of Predominance of triple wild-type and IGF2R mutations in mucosal melanomas

Yuuki Iida (5907662)
Matthew Salomon (3578312)
Keisuke Hata (510174)
Kevin Tran (519050)
Shuichi Ohe (5907671)
Chester Griffiths (5907674)
Sandy Hsu (117448)
Nellie Nelson (5907677)
Dave Hoon (5229374)

October 2018

Clinical characteristics of 89 melanomas. Description of data: Clinical information of each of the 8...

DataSheet_1_Comprehensive characterisation of immunogenic cell death in melanoma revealing the association with prognosis and tumor immune microenvironment.pdf

Jie Ren (176083)
Jiaqi Yang (4380466)
Song Na (13847077)
Yiqian Wang (51946)
Linyun Zhang (1552285)
Jinkui Wang (12011708)
Jiwei Liu (829376)

September 2022

Increasing evidence has highlighted the critical functions of immunogenic cell death (ICD) within ma...

Table_2_An enhanced genetic mutation-based model for predicting the efficacy of immune checkpoint inhibitors in patients with melanoma.xlsx

Chaohu Pan (11048957)
Hongzhen Tang (12216098)
Wei Wang (17594)
Dongfang Wu (585045)
Haitao Luo (365511)
Libin Xu (1314657)
Xue-Jia Lin (14434449)

January 2023

BackgroundProgrammed death ligand 1 (PD-L1) and tumor mutation burden (TMB) have been developed as b...

Table_1_An enhanced genetic mutation-based model for predicting the efficacy of immune checkpoint inhibitors in patients with melanoma.xlsx

Chaohu Pan (11048957)
Hongzhen Tang (12216098)
Wei Wang (17594)
Dongfang Wu (585045)
Haitao Luo (365511)
Libin Xu (1314657)
Xue-Jia Lin (14434449)

January 2023

BackgroundProgrammed death ligand 1 (PD-L1) and tumor mutation burden (TMB) have been developed as b...

Table_1_Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanoma.DOCX

Devayani Machiraju (14490179)
Sarah Schäfer (4642096)
Philip Beckhove (14490182)
Jasmin Roth (14490185)
Carsten Schulz (4023140)
Jessica C. Hassel (10677911)

January 2023

BackgroundImmune checkpoint inhibitors (ICIs) are the standard of care for metastatic cutaneous mela...

Additional file 1 of Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: a clinicogenomic TCGA study

Abstract

Extracted data

Additional file 1 of Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: a clinicogenomic TCGA study

Abstract

Extracted data

Topics

Related items

Topics

Related items